International Salmonella Typhimurium DT104 infections, 1992-2001

被引:192
作者
Helms, M [1 ]
Ethelberg, S [1 ]
Molbak, K [1 ]
机构
[1] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
关键词
D O I
10.3201/eid1106.041017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The incidence of multidrug-resistant (MDR) Salmonella Typhimurium infections in humans, and in particular MDR definitive phage type 104 (DT104), has increased substantially in many countries in the last 2 decades, often associated with increased illness. To examine the magnitude of this problem, a survey was conducted among countries with available antimicrobial resistance or phage typing surveillance data. A total of 29, primarily industrialized, countries participated in the survey, which covered the years 1992-2001. Overall, the incidence of MDR S. Typhimurium and DT104 increased continuously during this period, although the problem affected primarily Europe and North America. The increase appeared to have peaked in the United Kingdom but not in other countries. Also, the incidence of quinolone-resistant S. Typhimurium was increasing. This survey implies that MDR S. Typhimurium constitutes an increasing public health problem in large parts of the world and emphasizes the importance of surveillance and control programs.
引用
收藏
页码:859 / 867
页数:9
相关论文
共 40 条
  • [1] BACTERIOPHAGE-TYPING DESIGNATIONS OF SALMONELLA-TYPHIMURIUM
    ANDERSON, ES
    WARD, LR
    DESAXE, MJ
    DESA, JDH
    [J]. JOURNAL OF HYGIENE, 1977, 78 (02): : 297 - 300
  • [2] Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella:: Implications for the use of fluoroquinolones in food animals
    Angulo, FJ
    Johnson, KR
    Tauxe, RV
    Cohen, ML
    [J]. MICROBIAL DRUG RESISTANCE, 2000, 6 (01) : 77 - 83
  • [3] [Anonymous], SALMONELLOSEN MENSCH
  • [4] Development of quinolone resistance in Salmonella: Failure to prevent splenic abscess
    Boswell, TC
    Coleman, DJ
    Purser, NJ
    Cobb, RA
    [J]. JOURNAL OF INFECTION, 1997, 34 (01) : 86 - 87
  • [5] *CDCP, 2002, CDC SALM SURV ANN SU
  • [6] CHALKER RB, 1988, REV INFECT DIS, V10, P111
  • [7] DRUG-RESISTANT SALMONELLA IN THE UNITED-STATES - AN EPIDEMIOLOGIC PERSPECTIVE
    COHEN, ML
    TAUXE, RV
    [J]. SCIENCE, 1986, 234 (4779) : 964 - 969
  • [8] Crump JA, 2001, EMERG INFECT DIS, V7, P767
  • [9] FISHER I, 2001, EUROSURVEILLANCE WEE, V5
  • [10] Fisher I.S.T., 1999, Euro Surveill, V4, P52